TheProfitWatch

CRVS - Corvus Pharmaceuticals, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.46 0.11 (1.3%) -0.01 (-0.12%) -0.02 (-0.23%) -0.02 (-0.23%) 0.0 (0.0%) 0.06 (0.71%) 0.0 (0.0%) -0.09 (-1.05%)

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.1
Diluted EPS:
-0.1
Basic P/E:
-85.7
Diluted P/E:
-85.7
RSI(14) 1m:
58.47
VWAP:
8.57
RVol:

Events

Period Kind Movement Occurred At

Related News